Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 5,773-5,784 of 10,612

Drug study icon

TerminatedNCT03248713

Glucocorticoid Antagonist Treatment for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Drug study icon

CompletedNCT00515723

Glucose and Lipid Metabolism on Antipsychotic Medication

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Washington University School of Medicine
Condition: Schizophrenia

Drug study icon

CompletedNCT03321617

Glutamate Reducing Interventions in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 30 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Drug study icon

CompletedNCT02034253

Glutamate, Brain Connectivity and Duration of Untreated Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 17 Years to 35 Years

Countries: United States
Sponsor: University of Alabama at Birmingham
Condition: Schizophrenia

Drug study icon

Active Not RecruitingNCT04589208

Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Other study type icon

CompletedNCT01558557

Gluten Free Diet in People With Schizophrenia: A Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaOtherFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

WithdrawnNCT00000372

Glycine and D-Cycloserine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Schizophrenia

Drug study icon

CompletedNCT00291226

Glycine vs Placebo for the Schizophrenia Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 13 Years to 35 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Behavioral study icon

CompletedNCT04601194

Goal Elicitation, Treatment Prioritization, & Electronically-Practiced Discussion for Psychiatry

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Mental healthBehavioralOver 18 Years

Countries: United States
Sponsor: Indiana University
Condition: Mental health

Behavioral study icon

CompletedNCT01825746

Goal Setting for Health Behavior and Psychosocial Issues in Primary Care

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Anxiety, DepressionBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: Virginia Commonwealth University
Condition: Anxiety, Depression

Drug study icon

Active Not RecruitingNCT04801589

Goal-Directed Sedation in Mechanically Ventilated Infants and Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 44 Weeks to 11 Years

Countries: United States
Sponsor: Vanderbilt University Medical Center
Condition: PTSD

Behavioral study icon

CompletedNCT00307216

Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaBehavioralOver 18 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.